28 related articles for article (PubMed ID: 15028583)
1. Imidazoleacetic acid-ribotide: an endogenous ligand that stimulates imidazol(in)e receptors.
Prell GD; Martinelli GP; Holstein GR; Matulić-Adamić J; Watanabe KA; Chan SL; Morgan NG; Haxhiu MA; Ernsberger P
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13677-82. PubMed ID: 15365189
[TBL] [Abstract][Full Text] [Related]
2. Targeting fat to prevent diabetes.
Sethi JK; Vidal-Puig AJ
Cell Metab; 2007 May; 5(5):323-5. PubMed ID: 17488634
[TBL] [Abstract][Full Text] [Related]
3. Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans.
Cooper EJ; Hudson AL; Parker CA; Morgan NG
Eur J Pharmacol; 2003 Dec; 482(1-3):189-96. PubMed ID: 14660022
[TBL] [Abstract][Full Text] [Related]
4. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
Chan SL; Atlas D; James RF; Morgan NG
Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
6. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.
Chan SL; Brown CA; Morgan NG
Eur J Pharmacol; 1993 Jan; 230(3):375-8. PubMed ID: 8095024
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of efaroxan and beta-carbolines on the secretory activity of rodent and human beta cells.
Morgan NG; Cooper EJ; Squires PE; Hills CE; Parker CA; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():167-74. PubMed ID: 15028583
[TBL] [Abstract][Full Text] [Related]
9. Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview.
Chan SL
Gen Pharmacol; 1998 Oct; 31(4):525-9. PubMed ID: 9792210
[TBL] [Abstract][Full Text] [Related]
10. Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?
Morgan NG; Chan SL
Curr Pharm Des; 2001 Sep; 7(14):1413-31. PubMed ID: 11472276
[TBL] [Abstract][Full Text] [Related]
11. Imidazolines and pancreatic hormone secretion.
Morgan NG; Chan SL; Mourtada M; Monks LK; Ramsden CA
Ann N Y Acad Sci; 1999 Jun; 881():217-28. PubMed ID: 10415920
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the imidazoline binding site involved in regulation of insulin secretion.
Morgan NG; Chan SL; Brown CA; Tsoli E
Ann N Y Acad Sci; 1995 Jul; 763():361-73. PubMed ID: 7677348
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
